Literature DB >> 22495898

Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis.

Stéphanie Roberge1, Yves Giguère, Pia Villa, Kypros Nicolaides, Merja Vainio, Jean-Claude Forest, Peter von Dadelszen, Peter von Dadelzen, Daniel Vaiman, Sylvie Tapp, Emmanuel Bujold.   

Abstract

OBJECTIVE: To determine whether early administration of aspirin prevents severe and mild preeclampsia. STUDY
DESIGN: A systematic review and meta-analysis of randomized controlled trials were performed. Studies in which women were randomized at or before 16 weeks' gestation to low-dose aspirin versus placebo or no treatment were included. The outcomes of interest were severe preeclampsia and mild preeclampsia. Pooled relative risks with their 95% confidence intervals (CIs) were calculated.
RESULTS: Among 7941 citations retrieved, 352 were completely reviewed and four studies (392 women) fulfilled the inclusion criteria and were analyzed. When compared with controls, aspirin started at ≤16 weeks was associated with a significant reduction in severe (relative risk: 0.22, 95% CI: 0.08 to 0.57) but not mild (relative risk: 0.81, 95% CI: 0.33 to 1.96) preeclampsia.
CONCLUSION: Low-dose aspirin initiated at or before 16 weeks reduces the risk of severe preeclampsia, but not mild preeclampsia.
Copyright © 2012 by Thieme Medical Publishers

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22495898     DOI: 10.1055/s-0032-1310527

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  44 in total

1.  Severe diabetic nephropathy in type 1 diabetes and pregnancy--a case series.

Authors:  Giorgina B Piccoli; Elisabetta Tavassoli; Carmela Melluzza; Giorgio Grassi; Clara Monzeglio; Valentina Donvito; Filomena Leone; Rossella Attini; Sara Ghiotto; Roberta Clari; Irene Moro; Federica Fassio; Silvia Parisi; Eleonora Pilloni; Federica N Vigotti; Domenica Giuffrida; Alessandro Rolfo; Tullia Todros
Journal:  Rev Diabet Stud       Date:  2013-05-10

2.  Preeclampsia in high risk women is characterized by risk group-specific abnormalities in serum biomarkers.

Authors:  Torri D Metz; Amanda A Allshouse; Anna G Euser; Kent D Heyborne
Journal:  Am J Obstet Gynecol       Date:  2014-04-23       Impact factor: 8.661

Review 3.  Pregnancy-related liver disorders.

Authors:  Ashish Goel; Kapil D Jamwal; Anup Ramachandran; Kunissery A Balasubramanian; Chundamannil E Eapen
Journal:  J Clin Exp Hepatol       Date:  2013-03-16

4.  Population-based biomarker screening and the development of severe preeclampsia in California.

Authors:  Véronique Taché; Rebecca J Baer; Robert J Currier; Chin-Shang Li; Dena Towner; L Elaine Waetjen; Laura L Jelliffe-Pawlowski
Journal:  Am J Obstet Gynecol       Date:  2014-03-14       Impact factor: 8.661

5.  The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.

Authors:  Liona C Poon; Andrew Shennan; Jonathan A Hyett; Anil Kapur; Eran Hadar; Hema Divakar; Fionnuala McAuliffe; Fabricio da Silva Costa; Peter von Dadelszen; Harold David McIntyre; Anne B Kihara; Gian Carlo Di Renzo; Roberto Romero; Mary D'Alton; Vincenzo Berghella; Kypros H Nicolaides; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2019-05       Impact factor: 3.561

6.  Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia.

Authors:  Nandor Gabor Than; Roberto Romero; Adi Laurentiu Tarca; Katalin Adrienna Kekesi; Yi Xu; Zhonghui Xu; Kata Juhasz; Gaurav Bhatti; Ron Joshua Leavitt; Zsolt Gelencser; Janos Palhalmi; Tzu Hung Chung; Balazs Andras Gyorffy; Laszlo Orosz; Amanda Demeter; Anett Szecsi; Eva Hunyadi-Gulyas; Zsuzsanna Darula; Attila Simor; Katalin Eder; Szilvia Szabo; Vanessa Topping; Haidy El-Azzamy; Christopher LaJeunesse; Andrea Balogh; Gabor Szalai; Susan Land; Olga Torok; Zhong Dong; Ilona Kovalszky; Andras Falus; Hamutal Meiri; Sorin Draghici; Sonia S Hassan; Tinnakorn Chaiworapongsa; Manuel Krispin; Martin Knöfler; Offer Erez; Graham J Burton; Chong Jai Kim; Gabor Juhasz; Zoltan Papp
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561

Review 7.  The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus.

Authors:  Ozan Ünlü; Stephane Zuily; Doruk Erkan
Journal:  Eur J Rheumatol       Date:  2015-12-29

Review 8.  Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment?

Authors:  Guilherme R de Jesús; Gustavo Rodrigues; Nilson R de Jesús; Roger A Levy
Journal:  Curr Rheumatol Rep       Date:  2014-02       Impact factor: 4.592

9.  STOX1: a new player in preeclampsia?

Authors:  Eric M George; Gene L Bidwell
Journal:  Hypertension       Date:  2013-01-28       Impact factor: 10.190

Review 10.  Pre-eclampsia part 2: prediction, prevention and management.

Authors:  Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Steven J Korzeniewski; Lami Yeo; Roberto Romero
Journal:  Nat Rev Nephrol       Date:  2014-07-08       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.